Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients

• Aleksandra Markiewicz,

  Affiliations Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland, PostgraduateSchool of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland

  ⨯
• Marzena Wełnicka-Jaśkiewicz,

  Affiliation Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland

  ⨯
• Jarosław Skokowski,

  Affiliations Bank of Frozen Tissues and Genetic Specimens, Department of Medical Laboratory Diagnostics, Medical University of Gdańsk, Gdańsk, Poland, Department of Surgical Oncology, Medical University of Gdańsk, Gdańsk, Poland

  ⨯
• Janusz Jaśkiewicz,

  Affiliation Department of Surgical Oncology, Medical University of Gdańsk, Gdańsk, Poland

  ⨯
• Jolanta Szade,

  Affiliation Department of Pathology, Medical University of Gdańsk, Gdańsk, Poland

  ⨯
• Jacek Jassem,

  Affiliation Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland

  ⨯
• Anna J. Żaczek

  * E-mail: azaczek@gumed.edu.pl

  Affiliation Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Gdańsk, Poland

  ⨯